Release Date: 10/12/18 09:47 Summary: Termination of St Andrews acquisition Price Sensitive: Yes Download Document 133.84KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%